Galectin Therapeutics Inc (OQ:GALT)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for GALT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 10th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 18/19 Nov 15/19 Freeman Kevin D Indirect Ownership Common Stock P - Open market or private purchase 3,000 $3.36
Oct 15/19 Oct 10/19 10X Fund, L.P. Direct Ownership Common Stock S - Open market or private sale -17,000 $3.73
Sep 9/19 Sep 6/19 Freeman Kevin D Indirect Ownership Common Stock P - Open market or private purchase 1,290 $3.71
Sep 9/19 Sep 5/19 Amelio Gilbert F Direct Ownership Common Stock S - Open market or private sale 30,000 $3.30
Oct 15/19 Aug 2/19 10X Fund, L.P. Direct Ownership Common Stock J - Other transaction -38,690  
Jul 25/19 Jul 15/19 10X Fund, L.P. Direct Ownership Common Stock J - Other transaction -306  
Jun 5/19 Jun 4/19 Shlevin Harold H. Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,706  
Jun 5/19 Jun 4/19 Shlevin Harold H. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,706 $1.37
Jun 3/19 May 31/19 Uihlein Richard E Indirect Ownership Common Stock Purchase Warrant (right to buy) P - Open market or private purchase 25,700  
Jun 3/19 May 31/19 Uihlein Richard E Direct Ownership Common Stock Purchase Warrant (right to buy) P - Open market or private purchase 15,576,322  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for GALT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 10th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Nov 18/19 Nov 15/19 Freeman Kevin D Indirect Ownership Common Stock P - Open market or private purchase 3,000 $3.36
Oct 15/19 Oct 10/19 10X Fund, L.P. Direct Ownership Common Stock S - Open market or private sale -17,000 $3.73
Oct 15/19 Aug 2/19 10X Fund, L.P. Direct Ownership Common Stock J - Other transaction -38,690  
Sep 9/19 Sep 5/19 Amelio Gilbert F Direct Ownership Common Stock S - Open market or private sale 30,000 $3.30
Sep 9/19 Sep 6/19 Freeman Kevin D Indirect Ownership Common Stock P - Open market or private purchase 1,290 $3.71
Jul 25/19 Jul 15/19 10X Fund, L.P. Direct Ownership Common Stock J - Other transaction -306  
Jun 12/19 May 3/19 10X Fund, L.P. Direct Ownership Common Stock J - Other transaction -67,515  
Jun 5/19 Jun 4/19 Shlevin Harold H. Direct Ownership Stock option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,706  
Jun 5/19 Jun 4/19 Shlevin Harold H. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,706 $1.37
Jun 3/19 May 31/19 Uihlein Richard E Indirect Ownership Common Stock Purchase Warrant (right to buy) P - Open market or private purchase 25,700  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $GALT

StockTwits